Skip to main content

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Call for Papers

Treatment outcomes and paving the way for an HIV cure in Low and Middle Income Countries

Edited by  Dr Eric Arts, Dr Nicaise Ndembi and Dr Denis Tebit

Discussion of HIV treatment outcomes in LMICs has historically been neglected, even though it is in these countries that a cure is most crucial. This series covers the ways treatment outcomes can be improved along the way to a HIV cure in states defined as LMICs by the WHO.

Currently open for submissions - submit to the series here

Spatial inequality, infectious diseases and disease control
Cross-journal collection

Spatial inequality is the unequal distribution of resources and services across different areas or locations, such as healthcare, welfare, public services, household income and infrastructures, and it can be described in terms of proximity, distance, clustering and concentration. This collection brings together research that investigates the relationship between spatial inequalities of all kinds and the impact and prevalence of infectious diseases, including the impact of antimicrobial resistance.

Currently open for submissions - submit to the series here

Articles

Announcing the launch of In Review

AIDS Research and Therapy, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Aims and scope

AIDS Research and Therapy  publishes articles on basic science, translational, clinical, social, epidemiological, behavioral  and educational sciences articles focused on the treatment and prevention of HIV/AIDS, and the search for the cure.  The Journal publishes articles on novel and developing treatment strategies for AIDS as well as on the outcomes of established treatment strategies. Original research articles on animal models that form an essential part of the AIDS treatment research are also considered

Dr Eric Arts - Editor in Chief

Eric J Arts is Chair of the Department of Microbiology and Immunology at Western University in London, Canada. His research for the past 16 years described in over 120 publications has focused on HIV-1 fitness, evolution, and virulence in regards to transmission, disease progression, immune escape, drug resistance, and global HIV spread.

Since 1998, he has directed the research laboratories at the Joint Clinical Research Centre, Kampala, Uganda and has collaborated with investigators in Zimbabwe, China, Cameroon, Belgium, UK, France, Brazil, and Argentina. His research has been supported by grants from the NIH (NIAID, NICHD, and NHLBI), from the State of Ohio, Merck, and amfAR. He has served as chair and member of the NIH and CIHR grant panel and has reviewed grants for the many governments around the world.

Dr Nicaise Ndembi - Editor in Chief

Dr. Ndembi serves Director of Research at the Institute of Human Virology Nigeria, Adjunct Associate Professor, Division of Epidemiology and Prevention at the IHV, University of Maryland School of Medicine, US and Research Professor, Global Affairs Section, Kanazawa University, Japan.

Before that, Dr. Ndembi was head of the Virology Laboratory at the Uganda Virus Research Institute (MRC/UVRI and LSHTM Uganda Research Unit) where he supported several multi-country randomized controlled trials on HIV treatment strategy including the US Centers for Disease Control and Prevention (CDC) cluster-randomized trial to compare the effectiveness of home-based compared with facility-based delivery of antiretroviral therapy (Lancet 2009) and the UK Medical Research Council DART trial (Lancet 2010).

Dr. Ndembi has served on several scientific advisory panels and continues to serve as an advisor on HIV drug resistance and control policy to Nigeria’s Federal Ministry of Health. He is a member of the PharmAccess Technical Advisory board for the Pan-African Study for Evaluation of Resistance (PASER) in Africa (Lancet Infectious Diseases 2012) and WHOResistance Network TWG (Lancet 2012). He has authored/co-authored more than 100 publications in peer reviewed journals. He is PI and co-investigator on numerous US National Health Institute (NIH) grants.

Annual Journal Metrics